Mindfulness-based cognitive group therapy for women with breast and gynecologic cancer: a pilot study to determine effectiveness and feasibility.
Study Goal
The researchers aimed to investigate the effectiveness and acceptability of mindfulness-based cognitive therapy (MBCT) for women with breast and gynecologic cancer.
Results Summary
The study found significant improvements in distress, quality of life, mindfulness, and post-traumatic growth, with large effect sizes, and these gains were maintained 3 months post-intervention. Participants reported the program as beneficial, particularly its group-based nature.
Population
Women with breast and gynecologic cancer (n=50 recruited, n=42 completed, n=36 with complete data).
Effective Dosage
Eight weekly 2-hour mindfulness sessions.
Duration
8 weeks (plus 3-month follow-up).
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
mindfulness-based cognitive therapy (MBCT) | decrease | distress | women with breast and gynecologic cancer | ηρ(2) = 0.238 | Significant improvements with large effect sizes | #1 |
mindfulness-based cognitive therapy (MBCT) | increase | quality of life (QOL) | women with breast and gynecologic cancer | ηρ(2) = 0.204 | Significant improvements with large effect sizes | #2 |
mindfulness-based cognitive therapy (MBCT) | increase | mindfulness | women with breast and gynecologic cancer | ηρ(2) = 0.363 | Significant improvements with large effect sizes | #3 |
mindfulness-based cognitive therapy (MBCT) | increase | post-traumatic growth | women with breast and gynecologic cancer | ηρ(2) = 0.243 | Significant improvements with large effect sizes | #4 |
mindfulness-based cognitive therapy (MBCT) | no change | distress, quality of life (QOL), mindfulness, and post-traumatic growth | women with breast and gynecologic cancer | 3 months post-intervention | Gains were maintained | #5 |
mindfulness-based cognitive therapy (MBCT) | decrease | distress | women with breast and gynecologic cancer | - | decreased as a function of increased mindfulness | #6 |
mindfulness-based cognitive therapy (MBCT) | increase | quality of life (QOL) | women with breast and gynecologic cancer | - | decreased as a function of increased mindfulness | #7 |
mindfulness-based cognitive therapy (MBCT) | increase | post-traumatic growth | women with breast and gynecologic cancer | - | decreased as a function of increased mindfulness | #8 |
PURPOSE: Group-based mindfulness training is frequently described in psycho-oncology literature, but little is known of the effectiveness of mindfulness-based cognitive therapy (MBCT). We investigated the effectiveness and acceptability of MBCT for women with breast and gynecologic cancer. METHODS: Fifty women were recruited to participate in eight weekly 2-h mindfulness sessions. Outcomes of distress, quality of life (QOL), post-traumatic growth, and mindfulness were assessed pre-intervention, post-intervention, and again 3 months later using validated measures. Data were analyzed with repeated measures ANOVAs with a Bonferroni correction. Participant satisfaction and evaluation were also assessed. RESULTS: Forty-two women completed the program, and complete data were available for 36 women. Significant improvements with large effect sizes (ηρ(2)) were observed for distress (P < 0.001; ηρ(2) = 0.238), QOL (P = 0.001; ηρ(2) = 0.204), mindfulness (P < 0.001; ηρ(2) = 0.363) and post-traumatic growth (P < 0.001; ηρ(2) = 0.243). Gains were maintained 3 months post-intervention. Improvements in outcomes did not differ based on diagnostic group, psychological status, or physical well-being at entry. Change indices further support these findings. Scores on measures of distress, QOL, and post-traumatic growth decreased as a function of increased mindfulness at each time point (all P < 0.05). Participants reported experiencing the program as beneficial, particularly its group-based nature, and provided positive feedback of the therapy as a whole as well as its individual components. CONCLUSIONS: Within the limits of a non-randomized trial, these findings provide preliminary support for the potential psychosocial benefits of MBCT in a heterogeneous group of women with cancer. Future, more comprehensive trials are needed to provide systematic evidence of this therapy in oncology settings.